Haemonetics Corporation (HAE) Capital expenditures 2017–2026
Haemonetics Corporation (HAE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$32.8MFY2026 · since FY2017: $76.1M → $32.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $32.8M | -16.5% |
| FY2025 | $39.3M | +3.0% |
| FY2024 | $38.1M | -80.1% |
| FY2023 | $191.3M | +98.2% |
| FY2022 | $96.5M | +160.6% |
| FY2021 | $37.0M | -24.0% |
| FY2020 | $48.8M | -59.0% |
| FY2019 | $119.0M | +59.0% |
| FY2018 | $74.8M | -1.8% |
| FY2017 | $76.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice